{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:14:05Z","timestamp":1784045645020,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-03057-2","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:53:00Z","timestamp":1768006380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Viral kinetics in adults with Covid-19 treated with nirmatrelvir-ritonavir or molnupiravir: a population-based, observational cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Marlene","family":"Prager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Ensle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Eser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florentin","family":"Gl\u00f6tzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marton","family":"Szell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arschang","family":"Valipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zoufaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wenisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Burgmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Thalhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"G\u00f6tzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Karnthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Jorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"3057_CR1","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. [Internet]. 2024 Feb. Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/"},{"key":"3057_CR2","doi-asserted-by":"crossref","unstructured":"Harrington PR, Cong J, Troy SB, Rawson JMO, Julian;, O\u2019rear J et al. Morbidity and Mortality Weekly Report Evaluation of SARS-CoV-2 RNA Rebound After Nirmatrelvir\/Ritonavir Treatment in Randomized, Double-Blind, Placebo-Controlled Trials-United States and International Sites, 2021\u20132022 [Internet]. Vol. 22. 2023. Available from: www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2023\/217188Orig1s000ltr.pdf","DOI":"10.15585\/mmwr.mm7251a2"},{"issue":"3","key":"3057_CR3","doi-asserted-by":"publisher","first-page":"E537","DOI":"10.1093\/cid\/ciac481","volume":"76","author":"N Ranganath","year":"2023","unstructured":"Ranganath N, O\u2019Horo JC, Challener DW, Tulledge-Scheitel SM, Pike ML, O\u2019Brien M, et al. Rebound phenomenon after Nirmatrelvir\/Ritonavir treatment of coronavirus disease 2019 (COVID-19) in High-Risk persons. Clin Infect Dis. 2023;76(3):E537\u20139.","journal-title":"Clin Infect Dis"},{"key":"3057_CR4","doi-asserted-by":"crossref","unstructured":"Wong GLH, Yip TCF, Lai MSM, Wong VWS, Hui DSC, Lui GCY. Incidence of viral rebound after treatment with Nirmatrelvir-Ritonavir and molnupiravir. JAMA Netw Open. 2022;5(12):e2245086.","DOI":"10.1001\/jamanetworkopen.2022.45086"},{"issue":"11","key":"3057_CR5","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMc2206449","volume":"387","author":"ME Charness","year":"2022","unstructured":"Charness ME, Gupta K, Stack G, Strymish J, Adams E, Lindy DC, et al. Rebound of SARS-CoV-2 infection after Nirmatrelvir\u2013Ritonavir treatment. N Engl J Med. 2022;387(11):1045\u20137.","journal-title":"N Engl J Med"},{"issue":"3","key":"3057_CR6","doi-asserted-by":"publisher","first-page":"E241765","DOI":"10.1001\/jamanetworkopen.2024.1765","volume":"7","author":"Z Yang","year":"2024","unstructured":"Yang Z, Xu Y, Zheng R, Ye L, Lv G, Cao Z, et al. COVID-19 rebound after VV116 vs Nirmatrelvir-Ritonavir treatment: a randomized clinical trial. JAMA Netw Open. 2024;7(3):E241765.","journal-title":"JAMA Netw Open"},{"key":"3057_CR7","doi-asserted-by":"crossref","unstructured":"Schilling WHK, Jittamala P, Watson JA, Boyd S, et al; PLATCOV Collaborative Group. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial. Lancet Infect Dis. 2024;24(1):36\u201345.","DOI":"10.1186\/s12879-023-08835-3"},{"key":"3057_CR8","doi-asserted-by":"crossref","unstructured":"Esmaeili S, Owens K, Wagoner J, Polyak SJ, White JM, Schiffer JT. A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy. Nat Commun. 2024;15(1):5478.","DOI":"10.1038\/s41467-024-49458-9"},{"key":"3057_CR9","doi-asserted-by":"crossref","unstructured":"Phan T, Ribeiro RM, Edelstein GE, Boucau J, Uddin R, Marino C, et al. Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance. J Virol. 2025;99(3):e0162324.","DOI":"10.1128\/jvi.01623-24"},{"issue":"3","key":"3057_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.cmi.2024.10.026","volume":"31","author":"A Jorda","year":"2025","unstructured":"Jorda A, Ensle D, Eser H, Gl\u00f6tzl F, Riedl B, Szell M, et al. Real-world effectiveness of nirmatrelvir-ritonavir and molnupiravir in non-hospitalized adults with COVID-19: a population-based, retrospective cohort study. Clin Microbiol Infect. 2025;31(3):451\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"3057_CR11","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/cid\/ciaa619","volume":"71","author":"MR Tom","year":"2020","unstructured":"Tom MR, Mina MJ, Oxford University Press. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis. 2020;71:2252\u20134.","journal-title":"Clin Infect Dis"},{"issue":"15","key":"3057_CR12","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","volume":"386","author":"J Hammond","year":"2022","unstructured":"Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. Oral nirmatrelvir for High-Risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386(15):1397\u2013408.","journal-title":"N Engl J Med"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-03057-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03057-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03057-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:25:06Z","timestamp":1770391506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-025-03057-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":12,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3057"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-03057-2","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was given from the Ethics Committee of the City of Vienna (ID: EK23-146-VK).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}